Sinovac Biotech Stock Revenue
Sinovac Biotech fundamentals help investors to digest information that contributes to Sinovac Biotech's financial success or failures. It also enables traders to predict the movement of Sinovac Stock. The fundamental analysis module provides a way to measure Sinovac Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sinovac Biotech stock.
Sinovac |
Sinovac Biotech Company Revenue Analysis
Sinovac Biotech's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Sinovac Biotech Revenue | 213.17 M |
Most of Sinovac Biotech's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sinovac Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Sinovac Biotech reported 213.17 M of revenue. This is 97.2% lower than that of the Healthcare sector and 71.31% lower than that of the Biotechnology industry. The revenue for all United States stocks is 97.74% higher than that of the company.
Sinovac Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sinovac Biotech's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sinovac Biotech could also be used in its relative valuation, which is a method of valuing Sinovac Biotech by comparing valuation metrics of similar companies.Sinovac Biotech is currently under evaluation in revenue category among related companies.
Sinovac Fundamentals
| Return On Equity | 11.03 | |||
| Return On Asset | 4.53 | |||
| Profit Margin | 10.02 % | |||
| Operating Margin | 15.86 % | |||
| Current Valuation | 614.58 M | |||
| Shares Outstanding | 98.9 M | |||
| Shares Owned By Insiders | 15.89 % | |||
| Shares Owned By Institutions | 23.11 % | |||
| Number Of Shares Shorted | 199.77 K | |||
| Price To Earning | 48.65 X | |||
| Price To Book | 2.29 X | |||
| Price To Sales | 2.16 X | |||
| Revenue | 213.17 M | |||
| Gross Profit | 213.58 M | |||
| EBITDA | 38.49 M | |||
| Net Income | 15.35 M | |||
| Cash And Equivalents | 176.72 M | |||
| Cash Per Share | 1.79 X | |||
| Total Debt | 93.13 M | |||
| Debt To Equity | 0.28 % | |||
| Current Ratio | 2.98 X | |||
| Book Value Per Share | 2.83 X | |||
| Cash Flow From Operations | 22.17 M | |||
| Short Ratio | 47.51 X | |||
| Earnings Per Share | 0.13 X | |||
| Number Of Employees | 910 | |||
| Beta | 0.08 | |||
| Market Capitalization | 460.25 M | |||
| Total Asset | 202.98 M | |||
| Retained Earnings | (8.28 M) | |||
| Working Capital | 70.52 M | |||
| Current Asset | 128.52 M | |||
| Current Liabilities | 58 M | |||
| Z Score | 3.4 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| GM | General Motors | |
| CRM | Salesforce |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Sinovac Stock
If you are still planning to invest in Sinovac Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sinovac Biotech's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |